PMID: 15356379Sep 10, 2004Paper

The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor

Journal of Atherosclerosis and Thrombosis
Sadao TakahashiT Yamamoto

Abstract

The very low-density lipoprotein (VLDL) receptor is a member of the low-density lipoprotein (LDL) receptor family. In vitro and in vivo studies have shown that VLDL receptor binds triglyceride (TG)-rich lipoproteins but not LDL, and functions as a peripheral remnant lipoprotein receptor. VLDL receptor is expressed abundantly in fatty acid-active tissues (heart, skeletal muscle and fat), the brain and macrophages. It is likely that VLDL receptor functions in concert with lipoprotein lipase (LPL), which hydrolyses TG in VLDL and chylomicron. In contrast to the LDL receptor, VLDL receptor binds apolipoprotein (apo) E2/2 VLDL particles as well as apoE3/3 VLDL, and the expression is not down-regulated by intracellular lipoproteins. Recently, various functions of the VLDL receptor have been reported in lipoprotein metabolism, metabolic syndrome/atherosclerosis, cardiac fatty acid metabolism, neuronal migration and angiogenesis/tumor growth. Gene therapy of VLDL receptor into the liver showed a benefit effect for lipoprotein metabolism in both LDL receptor knockout and apoE mutant mice. Beyond its function as a peripheral lipoprotein receptor, possibilities of its physiological function have been extended to include signal transductio...Continue Reading

References

Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S TakahashiT Yamamoto
Apr 4, 1986·Science·M S Brown, J L Goldstein
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·P K FrykmanJ Herz
Jan 1, 1996·Circulation Research·H MasuzakiK Nakao
Mar 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·K L WyneH H Hobbs
Jan 1, 1995·Clinical and Experimental Pharmacology & Physiology. Supplement·H JingamiK Nakao
Dec 24, 1997·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·S KwokF B Kraemer
Dec 31, 1997·The Journal of Clinical Investigation·K M ArgravesD K Strickland
Nov 26, 1999·Neuron·G D'ArcangeloT Curran
Sep 15, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·J R GoudriaanM C Jong
Jun 8, 2002·Biochemical and Biophysical Research Communications·Akihisa KamatakiTokuo T Yamamoto
Jun 18, 2002·Symposia of the Society for Experimental Biology·G D'Arcangelo
Sep 16, 2003·Retina·John R HeckenlivelyBo Chang
Nov 18, 2003·The Journal of Clinical Investigation·Joachim Herz

❮ Previous
Next ❯

Citations

Aug 20, 2011·The British Journal of Nutrition·Tsuyoshi GotoSatoshi Nagaoka
Jul 21, 2011·Journal of Lipids·You-Guo Niu, Rhys D Evans
Feb 8, 2014·Canadian Journal of Physiology and Pharmacology·Dion R BrocksAyman O S El-Kadi
Aug 5, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Salim S El-AmouriDao Pan
Jan 5, 2006·Critical Reviews in Clinical Laboratory Sciences·Amanda J HooperJohn R Burnett
Jul 16, 2014·Critical Reviews in Biotechnology·Jeong-Hun KangMasaharu Murata
Dec 17, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tytteli A K TurunenSeppo Ylä-Herttuala
Nov 19, 2010·Forensic Science International : Synergy·Katsuyuki NakajimaMasaki Q Fujita
Sep 10, 2010·International Journal of Cardiology·Genovefa D KolovouKatherine K Anagnostopoulou
May 25, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Katsuaki SuzukiNorio Mori
Nov 16, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hyunsun JoJae Bum Kim
Mar 17, 2016·Biochimica Et Biophysica Acta·Rhys D Evans, David Hauton
Jul 23, 2015·Experimental Cell Research·Dorothee LasrichJoerg Heeren
Feb 12, 2008·Biochemical and Biophysical Research Communications·Yasuo ZenimaruIsamu Miyamori
Mar 4, 2015·Biochimica Et Biophysica Acta·Huan HuangFriedhelm Schroeder
Mar 23, 2011·Biochemical and Biophysical Research Communications·Sadao TakahashiMasashi Shiomi
Oct 14, 2016·Lipids in Health and Disease·Mohamed Abu-FarhaJehad Abubaker
Nov 26, 2009·The American Journal of Chinese Medicine·Hiroshi ShimodaMuh-Hwan Su
Feb 9, 2018·Nature Reviews. Cardiology·Børge G NordestgaardAnne Tybjærg-Hansen
Aug 2, 2017·European Journal of Preventive Cardiology·Andrea BaragettiAlberico L Catapano
Jul 12, 2018·Current Opinion in Lipidology·Theodosios D FilippatosMoses S Elisaf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.